Latest News

Appendix 4E & 2017 Financial Report Release 31-Aug-2017

Sienna has released its Appendix 4E and Financial Report for the period ended 30 June 2017. Thes.. READ MORE

Sienna Cancer Diagnostics (ASX:SDX) Lists On ASX 03-Aug-2017

Highlights: Sienna Cancer Diagnostics has listed on the Australian Securities Exchange (ASX).. READ MORE

Sienna Raises $4.6m From IPO 31-Jul-2017

Highlights: Sienna raised $4.6 million, adding approximately 470 new shareholders to the Com.. READ MORE

Investor Information

Sienna is a public unlisted company headquartered in Melbourne, Australia. In January 2015, Sienna transitioned from a purely Research and Development company to a true commercial entity with product revenues. The company has approximately 160 shareholders and is governed by an experienced board and management team, Sienna has benefited from over $5.7M in R&D Tax Incentive refunds and government grant programs, significantly bolstering investor contributions and facilitating the progress and growth to date. READ MORE

Research

Sienna’s core activities have historically focused on the clinical translation of biomarkers using novel diagnostic technologies for applications in pathology laboratories. The development of inexpensive, high performing in vitro diagnostic tests is expected to lead to radical changes in the approach to care and assessment of cancer patients – a change welcomed by clinicians and governments. READ MORE

About Sienna

Sienna is a medical technology company focussed on the development and commercialisation of novel IVD (in vitro diagnostic) tests. Sienna manufactures IVD products for pathology laboratories to use in their menu of testing services. Sienna has IVD product registration for their Anti-hTERT Antibody (SCD-A7) in several key markets including the USA, European Union and Australia. READ MORE

Sienna has launched the first ever IVD for detection of telomerase as an adjunct to urine cytology for assisting the diagnosis of bladder cancer.

– CEO, Matthew Hoskin

Contact Sienna

Sienna Cancer Diagnostics

1 Dalmore Drive Scoresby VIC 3179 Australia

Telephone +61 3 8288 2141 Facsimile +61 3 8288 2059